No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Healios KK: Confirmation
Healios KK: Financial Report - 14th Term (2024/01/01 - 2024/12/31)
Healios' ONE-BRIDGE Trial Data on ARDS Published in Regenerative Therapy
Healios K.K Submits Approval Application for ARDS Treatment in Japan
Helios, Synspective.
Nomura <4593> Helios BUY maintained <290A> Synspecitve BUY maintained *The ratings for the above companies are based on our confirmation as of December 3rd.
Jefferies Adjusts Healios' Price Target to 390 Yen From 320 Yen, Keeps at Buy